- Category
- Micro (2024-25)
- Udyam number
- UDYAM-GJ-22-0068324

Manch Pharmaceuticals Private Limited
About Manch Pharmaceuticals Private Limited
Data last updated:
Manch Pharmaceuticals Private Limited is a private limited company based in Surat, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 June 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24100GJ2014PTC079872. Its GSTIN is 24AAJCM2576K1Z5 (Gujarat).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Bhumikaben Manojbhai Sojitra and Manojbhai Rasikbhai Sojitra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Surat, Gujarat.
As per the financials filed for FY 2025, the company reported a revenue of ₹90.3 Lakh, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹76,470 (net margin 0.8%) and EBITDA of ₹1.09 Lakh (EBITDA margin 1.2%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 80% over five years.
Manch Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-22-0068324). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Manch Pharmaceuticals
Contact details
Manch Pharmaceuticals Private Limited's registered office is in Surat, Gujarat. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressShop No. 103 Ff Shivalik, Opp. Heny Heights Dabholi Brts Road Katargam, Surat, Gujarat, India – 395004
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Manch Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Manch Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Manch Pharmaceuticals Private Limited, buy the company report.
Financials of Manch Pharmaceuticals Private Limited
FY 2025 filings availableManch Pharmaceuticals Private Limited reported revenue of ₹90.3 Lakh (up 6% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 80% over five years, including 6% growth in the latest year. EBITDA rose 44% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.09 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹76,470 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.2% | ||||
| Net Profit Margin | 0.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Manch Pharmaceuticals Private Limited, buy the company report.
Board of directors of Manch Pharmaceuticals Private Limited
Manch Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhumikaben Manojbhai Sojitra | Director | 23 Jun 2014 | 12 Years 4 Months | Current |
| Manojbhai Rasikbhai Sojitra | Director | 23 Jun 2014 | 12 Years 4 Months | Current |
Peer comparison
Manch Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vedic Mediflow Device Private Limited | ₹90.33 Lakh (FY 2025) | -49.0% | Ahmedabad, Gujarat, India | |||
| Manch Pharmaceuticals Private Limitedthis company | ₹90.3 Lakh (FY 2025) | ₹76,470 | 0.8% | 6.0% | Surat, Gujarat, India | |
| Shree Life Sciences Private Limited | ₹90.06 Lakh (FY 2025) | 72.0% | Mumbai, Maharashtra, India | |||
| Tie Life Science Private Limited | ₹90.06 Lakh (FY 2018) | -23.0% | Mira Road, Maharashtra, India | |||
| Medsuvac Lifesciences Private Limited | ₹90.05 Lakh (FY 2024) | 82.0% | Rohini, Delhi, India |
To see the full peer comparison of Manch Pharmaceuticals Private Limited, buy the company report.
Auditor
Manch Pharmaceuticals Private Limited is audited by C K SHIYANI & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| C K SHIYANI & CO | FY 2019 | 142128W |
Shareholding
The shareholding of Manch Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Manch Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Manch Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Manch Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Manch Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAJCM2576K1Z5 | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Manch Pharmaceuticals Private Limited, buy the company report.
Recent activity
Manch Pharmaceuticals Private Limited has 2 board changes on record since 2014: 2 appointments. The latest: Bhumikaben Manojbhai Sojitra was appointed as Director on 23 Jun 2014.
Frequently asked questions
Manch Pharmaceuticals is an active private limited company based in Surat, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 June 2014 (12+ years old) and is registered under CIN U24100GJ2014PTC079872.
Manch Pharmaceuticals has 2 current directors:
- Bhumikaben Manojbhai Sojitra - Director
- Manojbhai Rasikbhai Sojitra - Director
The latest financial statements of Manch Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Manch Pharmaceuticals is 24AAJCM2576K1Z5, registered in Gujarat.
The CIN (Corporate Identification Number) of Manch Pharmaceuticals is U24100GJ2014PTC079872. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Manch Pharmaceuticals was incorporated on 23 June 2014, making it 12+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Manch Pharmaceuticals by revenue are Vedic Mediflow Device Private Limited, Shree Life Sciences Private Limited, Tie Life Science Private Limited, Medsuvac Lifesciences Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Bhumikaben Manojbhai Sojitra was appointed as Director on 23 Jun 2014. Manojbhai Rasikbhai Sojitra was appointed as Director on 23 Jun 2014.
Yes, Manch Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-GJ-22-0068324).
The registered office of Manch Pharmaceuticals is at Shop No. 103 Ff Shivalik, Opp. Heny Heights Dabholi Brts Road Katargam, Surat, Gujarat, India – 395004.
Manch Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.

